Breast Cancer Related Proteins Are Present in Saliva and Are Modulated Secondary to Ductal Carcinoma In Situ of the Breast

REFERENCES

• Wulfkuhle J. D., Liotta L. A., Petricoin E. F. Proteomic applications for the early detection of cancer. Nat. Rev. Can. 2003; 3: 267–75
   PubMed Web of Science ®Google Scholar
• Pollard T. The future of biomedical research, from the inventory of genes to understanding physiology and the molecular basis of disease. JAMA 2002; 287: 1725–27
   PubMed Web of Science ®Google Scholar
• Herrmann P. C., Liotta L., Petricoin E. Cancer Proteomics: The state of the art. Dis. Mkrs. 2001; 17: 49–57
   Google Scholar
• Srinivas P. R., Srivastava S., Hanash S., Wright G. L. Proteomics in early detection of cancer. Clin. Chem. 2001; 47(10)1901–11
   PubMed Web of Science ®Google Scholar
• Conrads T. P., Zhou M., Petricoin E., Liotta L., Veenstra T. Cancer diagnosis using proteomic patterns. Expert. Rev. Mol. Diag. 2003; 3(4)411–20
   PubMed Web of Science ®Google Scholar
• Simpson R. J., Dorow D. S. Cancer proteomics: From signaling networks to tumor markers. Trends Biotechnol. 2001; 19(10)S40–8
   PubMed Web of Science ®Google Scholar
• Verma M., Wright G. L., Hanash S. M., Gopal-Srivastava R., Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann. N. Y. Acad. Sci. 2001; 945: 103–15
   PubMed Web of Science ®Google Scholar
• von Eggeling F., Junker K., Fiedle W., Wollscheid V., Durst M., Claussen U., Ernst G. Mass spectrometry meets chip technology: a new proteomic tool in cancer research?. Electrophoresis 2001; 22(14)2898–902
   PubMed Web of Science ®Google Scholar
• Wong D. T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. JADA. 2006; 137: 313–21
   PubMed Web of Science ®Google Scholar
• Streckfus C. F., Bigler L., Dellinger T. D., Dai X., Kingman A., Thigpen J. T. The presence of c-erbB-2, and CA 15–3 in saliva and serum among women with breast carcinoma: a preliminary study. Clin. Cancer Res. 2000; 6(6)2363–70
   PubMed Web of Science ®Google Scholar
• Streckfus C. F., Bigler L., Tucci M., Thigpen J. T. The Presence of CA 15-3, c-erbB-2, EGFR, Cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000; 18(2)101–9
   PubMed Web of Science ®Google Scholar
• Bigler L. G., Streckfus C. F., Burns R., Copeland L., Dai X., Kuhn M., Martin P., Kaelbling M., Bigler S. A. The potential use of saliva to detect recurrence of disease in high-risk breast cancer patients. Oral Path Med. 2002; 31(7)421–431
   PubMed Web of Science ®Google Scholar
• Part V II. Breast. AJCC Cancer Staging Handbook. 6th ed., F. L. Greene, D. L. Page, I. D. Fleming, et al. Springer-Verlag, New York 2001
   Google Scholar
• Birkhed D., Heintze U. Salivary secretion rate, buffer capacity, and pH. Human Saliva: Clinical Chemistry and Microbiology-Volume 1, J. O. Tenovuo. CRC press, Boca Raton 1989
   Google Scholar
• Streckfus C. F., Bigler L., Dellinger T. D., Dai X., Cox W. J., McArthur A., Kingman A., Thigpen J. T. Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men. Oral. Surg. Oral. Med. Oral. Path. 2001; 91(2)174–180
   Google Scholar
• Wilmarth P. A., Riviere M. A., Rustvold D. L., Lauten J. D., Madden T. E., David L. L. Two dimensional liquid chromatography study of the human whole saliva proteome. J. Prot. Res. 2004; 3: 1017–23
   PubMed Web of Science ®Google Scholar
• Gu S., Liu Z., Pan S., Jiang Z., Lu H., Amit O., Bradbury E. M., Hu C. A., Chen X. Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol Cell Proteomics. 2004; 10: 998–1008
   Google Scholar
• Shevchenko A., Chernushevic I., Shevchenko A., Wilm M., Mann M. “De novo” sequencing of peptides recovered from in-gel digested proteins by nanoelectrospray tandem mass spectrometry. Mol. Biotech. 2002; 20: 107–18
   PubMed Web of Science ®Google Scholar
• Koomen J. M., Zhao H., Li D., Abbruzzese J., Baggerly K., Kobayashi R. Diagnostic protein discovery using proteolytic peptide targeting and identification. Rapid. Com. Mass. Spec. 2004; 18: 2537–48
   PubMed Web of Science ®Google Scholar
• Ward L. D., Reid G. E., Moritz R. L., Simpson R. J. Strategies for internal amino acid sequence analysis of proteins separated by polyacrylamide gel electrophoresis. J. Chroma. 1990; 519: 199–216
   PubMed Web of Science ®Google Scholar
• Hu S., Xie Y., Ramachandran P., Loo R. R.O., Li Y., Loo J. A., Wong D. T. Large scale identification of proteins in human saliva proteome by liquid chromatography/ mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics. 2005; 5: 1714–28
   PubMed Web of Science ®Google Scholar
• Huang C. M. Comparative proteomic analysis of human whole saliva. Arch. Oral. Biol. 2004; 49: 951–62
   PubMed Web of Science ®Google Scholar
• Vitorino R., Lobo M., Ferrer-Correira A. I., Dubin J. R., Tome K. B., Domingues P. M., Amado F. M. Identification of human whole saliva protein components using proteomics. Proteomics 2004; 4: 1109–15
   PubMed Web of Science ®Google Scholar
• Ghafouri B., Tagesson C., Lindahl M. Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2003; 3(6)1003–15
   PubMed Web of Science ®Google Scholar
• Minafra I. P., Cancemi P., Fontana S., et al. Expanding the protein catalogue in he proteome reference map of human breast cancer cells. Proteomics 2006; 6: 2609–25
   PubMed Web of Science ®Google Scholar
• Wulfkuhle J., Sgroi D., Krutzsch H., et al. Proteomics of human breast carcinoma in situ. Cancer Res. 2002; 62: 6740–9
   PubMed Web of Science ®Google Scholar
• Somiari R., Sullivan A., Russell S., et al. High–throughput proteomic analysis of infiltrating ductal carcinoma of the breast. Proteomics. 2003; 3: 1863–73
   PubMed Web of Science ®Google Scholar
• Hudelist G., Singer C., Pischinger K., et al. Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epithelium. Proteomics. 2006; 6: 1989–02
   PubMed Web of Science ®Google Scholar
• Chamberry A., Farina A., DiMaro A., et al. Proteomic analysis of MCF-7 cell lines expressing the Zinc finger or proline-rich domain of retinoblastoma-in reacting-zinc-finger protein. J. Proteome Res. 2006; 5: 1176–85
   PubMed Web of Science ®Google Scholar
• Polanski M., Anderson N L. A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights. 2006; 2: 1–48
   Google Scholar
• Sokol J. P., Neil J. R., Schiemann B. J., Schiemann W. P. The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β. Breast Can. Res. 2005; 7: R844–R853
   PubMed Web of Science ®Google Scholar
• Fernandez C. A., Li Y., Louis G., Yang J., Kutok J., Moses M. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Can. Res. 2005; 11(15)5390–5
   PubMed Web of Science ®Google Scholar
• Josephy P. D. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis. 1996; 11(1)3–7
   PubMed Web of Science ®Google Scholar
• Huang H. L., Stasyk T., Morandell S., Dieplinger H., et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 2006; 27: 1641–1650
   PubMed Web of Science ®Google Scholar
• Le X. F., Bedrosian I., Mao W., et al. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell Cycle 2006; 5(15)1654–61
   PubMed Web of Science ®Google Scholar
• Sonora C., Mazal D., Berois N., et al. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues. J Histochem Cytochem 2006; 54(3)289–299
   PubMed Web of Science ®Google Scholar
• Streckfus C. F., Bigler L. R., Dubinsky W. P., Bull J. Salivary biomarkers for the detection of cancer. Progress in Tumor Marker Research, L I Swenson. Nova Scientific Publishing, Inc., New York 2007
   Google Scholar
• Wick M., Ockner D. M., Mills S., Ritter J., Swanson P. E. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma and salivary duct carcinoma. Am. J. Clin. Pathol. 1998; 109: 75–84
   Google Scholar
• Kurachi H., Okamoto S., Oka T. Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. Proc. Natl. Acad. Sci. USA. 1985; 82: 5940–5943
   PubMed Web of Science ®Google Scholar
• Kuerer H. M., Thompson P. A., Krishnamurthy S., Fritsche H. A., Marcy S. M., Babiera G. V., et al. High and differential expression of HER2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin. Canc. Res. 2003; 9: 601–605
   PubMed Web of Science ®Google Scholar
• Alexander H., Stegner A. L., Wagner-Mann C., Du Bois G. C., Alexander S., Sauter E. R. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res. 2004; 10(22)7500–10
   PubMed Web of Science ®Google Scholar
• Charles F., Streckfus C. F., Dubinsky W. P. Proteomic analysis of saliva for cancer diagnosis. Exp Rev Prot. 2007; 4(3)329–332
   PubMed Web of Science ®Google Scholar